Cite
HARVARD Citation
Louis J, E. et al. (n.d.). OP01 Withdrawal of infliximab or anti-metabolite therapy in Crohn's Disease patients in sustained remission on combination therapy: A randomized unblinded controlled trial (SPARE). Journal of Crohn's and colitis. p. i001. [Online].